SEC FORM 4
$241,937.00
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Sale of 2,300 shares at $105.19 per share.
Reporting Person Meeker David P · Officer Title President and CEO · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001649904-26-000026 · filed 2026-09-14 · View filing →